910 CLOPPER ROAD, GAITHERSBURG, MD
Executive Appointment - Richard Menziuso Named VP, Global Controller
Announces Second Quarter 2026 Financial Results and Business Update
Ex-99.1
Other Events
Announces First Quarter 2026 Financial Results and Business Update
Altimmune, Inc. Enters Underwriting Agreement for $192.75 Million Offering
Altimmune, Inc. Amends Certificate of Incorporation to Increase Shares
Annual Report to Security Holders
Q2
Q1
FY 2025
Q3
FY 2023
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Additional Securities
Effectiveness Notice
Amended Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Submission Upload
Correspondence